<DOC>
	<DOCNO>NCT00057512</DOCNO>
	<brief_summary>The purpose study determine safety tolerability intratumoral M4N . Patients suffer cancer head neck recurrent primary treatment surgery , radiation therapy , and/or chemotherapy may eligible . The design Phase 1 dose escalation study M4N administer intratumorally weekly , initially three week . Dose escalate start schedule target 20 mg/cm3 tumor volume , new patient cohort schedule extend weekly M4N 4 week . Dose escalation continue , assume tolerability , cohort treat 6 week , finally , 8 week .</brief_summary>
	<brief_title>Study Intralesional Injection M4N Patients With Refractory Malignant Tumors Head Neck</brief_title>
	<detailed_description>Study data collect include pre-study demographic measurement , treatment compliance , efficacy determine tumor measurement , M4N level blood pharmacokinetics , serum biochemical determination , hematology determination , patient vital sign .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Masoprocol</mesh_term>
	<criteria>Male female patient ≥ 18 year age . Patients document histologic evidence head neck cancer clinically measurable disease . Head neck cancer could recurrent primary treatment surgery , radiation therapy and/or chemotherapy . Measurable tumor direct inspection , photography , image ( CT scan MRI ) . Life expectancy least 3 month Investigators ' opinion . Negative pregnancy test woman childbearing potential within 1 week start therapy . Patients provide write informed consent participate study . ECOG Performance Status 0 , 1 , 2 . Absolute neutrophil ≥ 1500/uL , hemoglobin ≥ 8 gm % , platelet ≥ 50,000/uL , ALT/AST ≤ 3 x ULN ( upper limit normal range ) , bilirubin ≤ 1.5 x ULN creatinine ≤ 1.5 x ULN , PT PTT within normal limit . Women pregnant nursing . Women child bear potential unwilling use adequate method contraception course study . Treatment prior investigational agent within 30 day enter study . Patients unable comply study requirement . Patients know sensitivity study medication component . Patients consent photography . Patients tumor envelop carotid artery whose anatomy distort Investigator 's opinion present highrisk perforation compromise injection . Prior chemotherapy , radiation therapy , surgery primary carcinoma within 30 day dose and/or recover prior therapy toxicity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2006</verification_date>
</DOC>